[HTML][HTML] Differentiated thyroid cancer with biochemical incomplete response: clinico-pathological characteristics and long term disease outcomes

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - Cancers, 2021 - mdpi.com
Simple Summary Biochemical incomplete response (BIR) is defined as elevated
thyroglobulin or rising thyroglobulin antibodies following treatment without structural …

Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - Cancers, 2021 - europepmc.org
Although most patients with differentiated thyroid cancer (DTC) and biochemical incomplete
response (BIR) follow a good clinical outcome, progression to structural disease may occur …

[PDF][PDF] Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes. Cancers 2021 …

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - 2021 - pdfs.semanticscholar.org
Although most patients with differentiated thyroid cancer (DTC) and biochemical incomplete
response (BIR) follow a good clinical outcome, progression to structural disease may occur …

Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - …, 2021 - search.proquest.com
Although most patients with differentiated thyroid cancer (DTC) and biochemical incomplete
response (BIR) follow a good clinical outcome, progression to structural disease may occur …

Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Biochemical incomplete response (BIR) is defined as elevated
thyroglobulin or rising thyroglobulin antibodies following treatment without structural …

[HTML][HTML] Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - Cancers, 2021 - ncbi.nlm.nih.gov
Although most patients with differentiated thyroid cancer (DTC) and biochemical incomplete
response (BIR) follow a good clinical outcome, progression to structural disease may occur …

Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes

M Steinschneider, J Pitaro, S Koren, Y Mizrakli… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Although most patients with differentiated thyroid cancer (DTC) and biochemical incomplete
response (BIR) follow a good clinical outcome, progression to structural disease may occur …